CTRI/2024/07/069868已完成2 期
Open label randomised controlled trial of Telmisartan in Raynauds phenomenon associated with Systemic Lupus Erythematosus and Rheumatoid Arthritis
Institute of Medical Sciences Banaras Hindu University Varanasi Uttar Pradesh 2210051 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2024年11月1日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
- 试验地点
- 1
- 主要终点
- Improvement in severity and frequency of Raynauds Phenomenon after introduction of drug with standard of care
研究概览
简要总结
Registered cases will randomised into 2 groups of 10 patients each, all patients will receive standard of care ( Tadalafil with cold protective measures), one arm of the study (10patients) will receive Telmisartan (20- 40mg) and the other group will receive Nifedipine (10 - 20mg), they will be then followed up at 6 and 12 weeks with Raynauds condtion score which will assess the frequency and severity of Raynauds Phenomenon
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 65.00 Year(s)（—）
- 性别
- All
入选标准
- •Age greater than or equal to 18 years.
- •Patients diagnosed as Systemic Lupus Erythematosus and Rheumatoid Arthritis with history of Raynaud’s Phenomenon.
- •Willing to give signed written consent.
排除标准
- •1.Any co-existing significant/incapacitating chronic illness 2.Patient with symptomatic CAD 3.Patients on oral or sublingual nitrates 4.Patient who are pregnant or reproductive couples who have intention of pregnancy 5.Patients with known contraindication to either of IPs or SOC.
结局指标
主要结局
Improvement in severity and frequency of Raynauds Phenomenon after introduction of drug with standard of care
时间窗: 0,6 and 12 weeks
次要结局
- Any untoward effect or hypersensitivity(At 1 and 2 weeks)
研究者
Rajat Singh
Institute of Medical Sciences
研究点 (1)
Loading locations...
相似试验
尚未招募
2 期
To see if Telmisartan helps to improve the symtoms of Raynauds Phenomena (discoloration/pain in fingers on exposure to cold temperatures) in patients of Systemic sclerosis or MCTDCTRI/2024/07/069866Institute of Medical Sciences Banaras Hindu University Varanasi Uttar Pradesh 22100520
尚未招募
不适用
Comparative study of telmisartan and amlodipine combination vs telmisartan in Indian patients with high blood pressureCTRI/2025/10/095719Torrent Pharmaceuticals Ltd.14,000
尚未招募
2 期
Effect of Ayurvedic medicine in Hypothyroidism.CTRI/2025/02/081276Shraddha Dattatray Satre80
尚未招募
不适用
My study is about comparing the changes in blood pressure in patients having BP 140/90 to 160/100 mmHg with Vitamin D levels of 20 to 29 ng/mL taking standard of treatment which is tablet Telmisartan 40mg alone in one group and tablet Telmisartan 40mg with Vitamin D supplementation in another groupCTRI/2025/11/09759284
招募中
3 期
Evaluating the Role of Amino Acid Infusions in Faster Recovery for Dengue Patients.CTRI/2024/12/078475Dr Deepan K96